Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E Chicago Ave
Chicago, IL 60611Phone+1 312-227-4000
Summary
- I am a board certified Neurologist with special qualifications in Child neurology and Neuromuscular medicine. I jointly run the muscular dystrophy association clinic at Lurie Childrens Hospital in Chicago.
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014
- McGaw Medical Center of Northwestern UniversityFellowship, Child Neurology, 2010 - 2013
- Cook County Health and Hospitals SystemResidency, Pediatrics, 2006 - 2009
- B.J. Medical College - University of PuneClass of 2000
Certifications & Licensure
- IL State Medical License 2006 - 2026
- NE State Medical License 2014 - 2016
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2016 Dec 01
- Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2017 Jul 06
- Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)
Publications & Presentations
PubMed
- 1307 citationsNusinersen versus Sham Control in Infantile-Onset Spinal Muscular AtrophyRichard S. Finkel, Eugenio Mercuri, Basil T. Darras, Anne M. Connolly, Nancy L. Kuntz
The New England Journal of Medicine. 2017-11-01 - 13 citationsSymptomatic Cerebral Vasospasm Following Resection of a Medulloblastoma in a ChildVamshi K. Rao, Abilash Haridas, Thanh D. Nguyen, Rishi Lulla, Mark S. Wainwright
Neurocritical Care. 2013-02-01 - 53 citationsCombination molecular therapies for type 1 spinal muscular atrophy.Yohei Harada, Vamshi K. Rao, Kapil Arya, Nancy L. Kuntz, Christine J. DiDonato
Muscle & Nerve. 2020-07-25
Journal Articles
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingPaula R Clemens, Vamshi K Rao, Craig M Zaidman, JAMA Neurology
Authored Content
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 2020
Press Mentions
- Gene Therapy SGT-001 Improves Lung Function in DMD Boys in TrialSeptember 30th, 2021
- VILTEPSO® (Viltolarsen) Injection Interim Long-Term Clinical Trial Data Scheduled for Presentation at the Child Neurology Society Annual MeetingSeptember 22nd, 2021
- SLDB Stock Alert: Dear Solid Biosciences Investors, Mark Your Calendar for Sept. 23!September 21st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: